GlassScriptPhysician profile
Harrison J Glassman
NPI 1811151608
$9,402.55
in general payments reported to CMS, 2019-2025
30 companies · $996 in 2025
The $996 reported for 2025 was more than what 79% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,875 · 2020: $461 · 2021: $1,560 · 2022: $833 · 2023: $813 · 2024: $865 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,673.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $4,025.50 | 2019-2025 | |
| Genzyme Corporation | $1,367.24 | 2019-2025 | |
| Glaxosmithkline, LLC. | $685.90 | 2020-2025 | Nucala |
| Medical Device Business Services, INC. | $613.66 | 2021 | |
| Acclarent, INC | $340.85 | 2019-2024 | Acclarent Aera |
| Astrazeneca Pharmaceuticals LP | $311.62 | 2019-2025 | Fasenra, Tezspire |
| Neurent Medical Limited | $303.60 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Kaleo, INC. | $247.67 | 2019-2024 | Auvi-Q |
| Regeneron Healthcare Solutions, INC. | $195.56 | 2019-2023 | Dupixent |
| Medtronic, INC. | $160.01 | 2023-2025 | Propel, Sinuva |
| Stryker Corporation | $149.45 | 2019-2022 | |
| Shire North American Group INC | $111.05 | 2019 | |
| Intersect Ent, INC. | $108.76 | 2019-2021 | |
| Grifols USA, LLC | $94.23 | 2019-2024 | Xembify |
| Integra Lifesciences Corporation | $91.68 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $87.01 | 2019-2020 | |
| Alk-Abello, INC | $71.96 | 2019-2021 | |
| Amgen INC. | $64.79 | 2022-2025 | Tezspire |
| Csl Behring | $57.90 | 2019-2020 | |
| Aerin Medical INC. | $54.55 | 2019 | |
| Inspire Medical Systems, INC. | $54.03 | 2023 | Inspire |
| Paratek Pharmaceuticals, INC. | $42.60 | 2025 | Xhance |
| Merck Sharp & Dohme LLC | $32.29 | 2023 | |
| Abbvie INC. | $28.20 | 2022 | |
| Hologic Sales and Service, LLC | $24.05 | 2024 | Coolseal Generator |
| Takeda Pharmaceuticals U.S.A., INC. | $20.61 | 2025 | Cuvitru |
| Phadia US INC. | $16.74 | 2019 | |
| Incyte Corporation | $15.25 | 2022 | |
| Pfizer INC. | $13.85 | 2019 | |
| Hikma Pharmaceuticals USA | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harrison Glassman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.